Drew has worked in the cell and gene therapy sector for the majority of his 30-year career in biotechnology research, translation, and clinical application. He is driven by the implementation of Advanced Therapies to overcome the needs of patients for whom standard pharmaceutical solutions are lacking. Drew has a scientific background coupled with extensive experience in quality functions, including as a certifying qualified person with direct cell and gene therapy experience.